Semaglutide and fatty liver: what we know
Semaglutide (Ozempic, Rybelsus) may improve MASH in selected patients, but it does not replace fibrosis assessment. Learn about its benefits, limitations and risks.
Steatotic liver disease (MASLD): the most common cause of liver damage in Chile.
Semaglutide (Ozempic, Rybelsus) may improve MASH in selected patients, but it does not replace fibrosis assessment. Learn about its benefits, limitations and risks.
Fatty liver on ultrasound is common and usually treatable. Learn which tests you may need and how doctors assess the risk of liver fibrosis.
Fatty liver, now called metabolic dysfunction-associated steatotic liver disease (MASLD), is the most common liver disease. What it is, how it is diagnosed and how it is treated.
Is fatty liver serious? Can it be cured? What diet should you follow? Clear answers to the 12 most common questions about fatty liver (MASLD).